Partnering with CrOs tO DevelOP high-Quality aDCs Key Bioanalytical Strategies aDCs are a breakthrOugh CanCer treatment that Can Deliver CytOtOxins DireCtly tO CanCer Cells withOut the sweePing COllateral Damage Of traDitiOnal ChemOtheraPy

نویسنده

  • Franklin Spriggs
چکیده

Antibody drug conjugates (ADCs) have grown extremely popular in the pharma industry with 238 clinical trials testing 47 unique ADCs in 20141, but these are complex molecules that need careful development of a bioanalytical strategy to inform the clinical team as to the exposure, safety, and risk profiles of the dosed molecule. This article will highlight some of the key bioanalytical strategies used to support ADC programs, the critical challenges associated with this development and subsequent validations, and hurdles that biopharma companies and CROs may neglect to consider.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The Role of microRNA in Cancer Cachexia and Muscle Wasting: A Review Article

Almost half of cancer patients experience cachexia syndrome. Cachexic patients are at risk of increased side effects of chemotherapy, reduced tolerance to chemotherapy drugs, longer duration of treatment period, and decreased quality of life. Cancer cachexia is a multifactorial syndrome. Micro ribonucleic acid (miRNA), a “non-coding RNA”, is considered to be a risk factor of cachexia and muscle...

متن کامل

Antibody–drug conjugates as novel anti-cancer chemotherapeutics

Over the past couple of decades, antibody-drug conjugates (ADCs) have revolutionized the field of cancer chemotherapy. Unlike conventional treatments that damage healthy tissues upon dose escalation, ADCs utilize monoclonal antibodies (mAbs) to specifically bind tumour-associated target antigens and deliver a highly potent cytotoxic agent. The synergistic combination of mAbs conjugated to small...

متن کامل

Marine Antibody–Drug Conjugates: Design Strategies and Research Progress

Antibody-drug conjugates (ADCs), constructed with monoclonal antibodies (mAbs), linkers, and natural cytotoxins, are innovative drugs developed for oncotherapy. Owing to the distinctive advantages of both chemotherapy drugs and antibody drugs, ADCs have obtained enormous success during the past several years. The development of highly specific antibodies, novel marine toxins' applications, and ...

متن کامل

Nanomedicine – The role of newer drug delivery technologies in cancer

Nanotechnology has slowly but steadily revolutionized the diagnosis, imaging and treatment of cancer. Detecting cancer at earliest stages, locating the tumor at different areas in the body and specific delivery of the drugs to malignant cells including surgically inaccessible tumors are the core areas of medical and pharmaceutical research across the world. In this endeavour, Nanodevices have e...

متن کامل

High-Speed and Low-Power Flash ADCs Encoder

This paper presents a high-speed, low-power and low area encoder for implementation of flash ADCs. Key technique for design of this encoder is performed by convert the conventional 1-of-N thermometer code to 2-of-M codes (M = ¾ N). The proposed encoder is composed from two-stage; in the first stage, thermometer code are converted to 2-of-M codes by used 2-input AND and 4-i...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2015